Contemporary Considerations in the Evolution of Wearable Technology
for Arrhythmia Detection

Tobin      Joseph; Mahmoud      Barrie; Akbar      Karimi; Sharmi      Haque; Innocent      Ogunmwonyi; Utkarsh      Ojha

doi:10.2174/1573403X19666230811093048

Abstract

Arrhythmias are an increasingly common cause of hospital admissions worldwide. Late detection of arrhythmias is associated with a significantly increased risk of cardiovascular complications. Early identification and management of life-threatening arrhythmias is paramount to reduce mortality. Wearable technologies are now widespread among the general population, providing a continuous output of healthcare data. However, this data are not routinely integrated into clinical practice. Here, we begin by outlining the current landscape in wearable technology for aiding arrhythmia detection; we then consider the clinical impact of wearable technology for both clinicians and patients; we further highlight the latest and emerging trials in wearable technology for arrhythmia detection and finally postulate the wider implications of the expansion of such cardiac devices.

Graphical Abstract

[1]
Desai DS, Hajouli S. Arrhythmias.StatPearls. Treasure Island, FL: StatPearls Publishing 2022.

[2]
Khurshid S, Choi SH, Weng LC, et al. Frequency of cardiac rhythm abnormalities in a half million adults. Circ Arrhythm Electrophysiol  2018; 11(7): e006273.
 [http://dx.doi.org/10.1161/CIRCEP.118.006273] [PMID:  29954742]

[3]
Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J  2021; 42(5): 373-498.
 [http://dx.doi.org/10.1093/eurheartj/ehaa612] [PMID:  32860505]

[4]
Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J  2020; 41(5): 655-720.
 [http://dx.doi.org/10.1093/eurheartj/ehz467] [PMID:  31504425]

[5]
Halcox JPJ, Wareham K, Cardew A, et al. Assessment of remote heart rhythm sampling using the alivecor heart monitor to screen for atrial fibrillation. Circulation  2017; 136(19): 1784-94.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.117.030583] [PMID:  28851729]

[6]
Burdett P, Lip GYH. Atrial fibrillation in the UK: Predicting costs of an emerging epidemic recognizing and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes  2022; 8(2): 187-94.
 [http://dx.doi.org/10.1093/ehjqcco/qcaa093] [PMID:  33346822]

[7]
Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med  2014; 127(1): 95.e11-7.
 [http://dx.doi.org/10.1016/j.amjmed.2013.10.003] [PMID:  24384108]

[8]
Bisignani A, De Bonis S, Mancuso L, Ceravolo G, Bisignani G. Implantable loop recorder in clinical practice. J Arrhythm  2019; 35(1): 25-32.
 [http://dx.doi.org/10.1002/joa3.12142] [PMID:  30805041]

[9]
Smith A, Perdue M, Vojnika J, Frisch DR, Pavri BB. The diagnostic yield of implantable loop recorders stratified by indication: “Real-world” use in a large academic hospital. J Interv Card Electrophysiol  2021; 61(2): 303-11.
 [http://dx.doi.org/10.1007/s10840-020-00815-w] [PMID:  32621215]

[10]
Kajdič N, Zupan Mežnar A, Šinkovec M, Žižek D. Diagnostic yield of implantable loop recorders in patients with unexplained syncope: single-center experience. Minerva Cardiol Angiol  2021; 69(4): 419-25.
 [http://dx.doi.org/10.23736/S2724-5683.20.05247-0] [PMID:  32989968]

[11]
Davis S, Westby M, Pitcher D, Petkar S. Implantable loop recorders are cost-effective when used to investigate transient loss of consciousness which is either suspected to be arrhythmic or remains unexplained. Europace  2012; 14(3): 402-9.
 [http://dx.doi.org/10.1093/europace/eur343] [PMID:  22071383]

[12]
Rinciog CI, Sawyer LM, Diamantopoulos A, et al. Cost-effectiveness of an insertable cardiac monitor in a high-risk population in the UK. Open Heart  2019; 6(1): e001037.
 [http://dx.doi.org/10.1136/openhrt-2019-001037] [PMID:  31297227]

[13]
Svendsen JH, Diederichsen SZ, Højberg S, et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): A randomised controlled trial. Lancet  2021; 398(10310): 1507-16.
 [http://dx.doi.org/10.1016/S0140-6736(21)01698-6] [PMID:  34469766]

[14]
Adasuriya G, Haldar S. Remote monitoring of cardiac arrhythmias using wearable digital technology: Paradigm shift or pipe dream? Eur J Arrhythm Electrophysiol  2022; 8(1): 7-12.
 [http://dx.doi.org/10.17925/EJAE.2022.8.1.7]

[15]
Laricchia F. Number of connected wearable devices worldwide	from 2019 to 2022. 2022.  Available from :  https://www.statista.com/statistics/487291/global-connected-wearable-devices/
           [Accessed on: Aug. 27, 2022].
      

[16]
Levine DM, Lipsitz SR, Linder JA. Trends in seniors’ use of digital health technology in the United States, 2011-2014. JAMA  2016; 316(5): 538-40.
 [http://dx.doi.org/10.1001/jama.2016.9124] [PMID:  27483069]

[17]
Ding EY, Marcus GM, McManus DD. Emerging technologies for identifying atrial fibrillation. Circ Res  2020; 127(1): 128-42.
 [http://dx.doi.org/10.1161/CIRCRESAHA.119.316342] [PMID:  32716695]

[18]
Hampton JR. The ECG made easy.  (8th ed.), Edinburgh: Churchill Livingstone/Elsevier 2013.

[19]
Pereira T, Tran N, Gadhoumi K, et al. Photoplethysmography based atrial fibrillation detection: A review. NPJ Digit Med  2020; 3(1): 3.
 [http://dx.doi.org/10.1038/s41746-019-0207-9] [PMID:  31934647]

[20]
Ghamari M, Esparza A, Ghamari M, Soltanpur C, Nazeran H. A review on wearable photoplethysmography sensors and their potential future applications in health care. Int J Biosens Bioelectron  2018; 4(4): 195-202.
 [http://dx.doi.org/10.15406/ijbsbe.2018.04.00125] [PMID:  30906922]

[21]
Prieto-Avalos G, Cruz-Ramos NA, Alor-Hernández G, Sánchez-Cervantes JL, Rodríguez-Mazahua L, Guarneros-Nolasco LR. Wearable devices for physical monitoring of heart: A review. Biosensors  2022; 12(5): 292.
 [http://dx.doi.org/10.3390/bios12050292] [PMID:  35624593]

[22]
Seshadri DR, Bittel B, Browsky D, et al. Accuracy of apple watch for detection of atrial fibrillation. Circulation  2020; 141(8): 702-3.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044126] [PMID:  32091929]

[23]
National Institute for Health and Care Excellence Atrial fibrillation: diagnosis and management 2021.  Available from:https://www.nice.org.uk/guidance/ng196
          Accessed on: Aug. 27,	2022).
      

[24]
Overbeek DL, Hogikyan EM, Davis M, McGillicuddy DC. A unique case of bradycardia recognized by wearable technology as first presentation of complete heart block - PubMed. Am J Emerg Med  2021; 37(10): e5-1989.e7.

[25]
Walsh KA, Lin D. A smartwatch heart rate monitor prompts an unusual diagnosis. JACC Case Rep  2020; 2(3): 431-3.
 [http://dx.doi.org/10.1016/j.jaccas.2019.11.087] [PMID:  34317256]

[26]
Burke J, Haigney MCP, Borne R, Krantz MJ. Smartwatch detection of ventricular tachycardia: Case series. HeartRhythm Case Rep  2020; 6(10): 800-4.
 [http://dx.doi.org/10.1016/j.hrcr.2020.08.003] [PMID:  33101960]

[27]
Rizas KD, Freyer L, Sappler N, et al. Smartphone-based screening for atrial fibrillation: A pragmatic randomized clinical trial. Nat Med  2022; 28(9): 1823-30.
 [http://dx.doi.org/10.1038/s41591-022-01979-w] [PMID:  36031651]

[28]
Lubitz SA, Faranesh AZ, Selvaggi C, et al. Detection of atrial fibrillation in a large population using wearable devices: The fitbit heart study. Circulation  2022; 146(19): 1415-24.
 [http://dx.doi.org/10.1161/CIRCULATIONAHA.122.060291] [PMID:  36148649]

[29]
Bayoumy K, Gaber M, Elshafeey A, et al. Smart wearable devices in cardiovascular care: Where we are and how to move forward. Nat Rev Cardiol  2021; 18(8): 581-99.
 [http://dx.doi.org/10.1038/s41569-021-00522-7] [PMID:  33664502]

[30]
Nielsen JC, Lin YJ, de Oliveira Figueiredo MJ, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: Use the right tool for the right outcome, in the right population. Europace  2020; 22(8): 1147-8.
 [http://dx.doi.org/10.1093/europace/euaa065] [PMID:  32538434]

[31]
ClinicalTrialsgov A Study of the Acceptability and Performance of Wearables for Atrial Fibrillation Screening in Older Adults Bethesda (MD). US: National Library of Medicine 2021.

[32]
ClinicalTrials.gov Remote Monitoring of AF Recurrence Using mHealth Technology 2021.

[33]
ClincalTrials.gov. A Study to Investigate if Early Atrial Fibrillation	(AF) Diagnosis Reduces Risk of Events Like Stroke in the RealWorld. 

[34]
ClinicalTrials.gov Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation. 

[35]
Wang L, Nielsen K, Goldberg J, et al. Association of wearable device use with pulse rate and health care use in adults with atrial fibrillation. JAMA Netw Open  2021; 4(5): e215821.
 [http://dx.doi.org/10.1001/jamanetworkopen.2021.5821] [PMID:  34042996]

[36]
Ferguson C, Hickman LD, Turkmani S, Breen P, Gargiulo G, Inglis SC. “Wearables only work on patients that wear them”: Barriers and facilitators to the adoption of wearable cardiac monitoring technologies. Cardiovasc Digit Health J  2021; 2(2): 137-47.
 [http://dx.doi.org/10.1016/j.cvdhj.2021.02.001] [PMID:  35265900]

[37]
Smuck M, Odonkor CA, Wilt JK, Schmidt N, Swiernik MA. The emerging clinical role of wearables: factors for successful implementation in healthcare. NPJ Digit Med  2021; 4(1): 45.
 [http://dx.doi.org/10.1038/s41746-021-00418-3] [PMID:  33692479]

[38]
Predel C, Steger F. Ethical challenges with smartwatch-based screening for atrial fibrillation: Putting users at risk for marketing purposes? Front Cardiovasc Med  2021; 7: 615927.
 [http://dx.doi.org/10.3389/fcvm.2020.615927] [PMID:  33521064]

[39]
Assessing fitness to drive: A guide for medical professionals. Driver and Vehicle Licensing Agency 2022.

[40]
Guest AJ, Chen YL, Pearson N, King JA, Paine NJ, Clemes SA. Cardiometabolic risk factors and mental health status among truck drivers: A systematic review. BMJ Open  2020; 10(10): e038993.
 [http://dx.doi.org/10.1136/bmjopen-2020-038993] [PMID:  33099498]

[41]
Wearable Technology Market Size, Trends, Growth, Report 2030	Precedence Research. 2022. Available from:   https://www.precedenceresearch.com/wearable-technology-market
          [Accessed on: Jun. 26, 2023].
      

[42]
Baranchuk A, Refaat MM, Patton KK, et al. Cybersecurity for cardiac implantable electronic devices. J Am Coll Cardiol  2018; 71(11): 1284-8.
 [http://dx.doi.org/10.1016/j.jacc.2018.01.023] [PMID:  29475627]

[43]
MW is Short St Jude Medical (STJ:US) - Muddy Waters Research.  2016. Available from:  https://www.muddywatersresearch.com/research/stj/mw-is-short-stj/
          Accessed on: Jun. 26, 2023].
      

[44]
Tran VT, Riveros C, Ravaud P. Patients’ views of wearable devices and AI in healthcare: Findings from the ComPaRe e-cohort. NPJ Digit Med  2019; 2(1): 53.
 [http://dx.doi.org/10.1038/s41746-019-0132-y] [PMID:  31304399]

Rights & Permissions Print Cite

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1573403X19666230811093048	Print ISSN 1573-403X
Publisher Name Bentham Science Publisher	Online ISSN 1875-6557

Current Cardiology Reviews

Contemporary Considerations in the Evolution of Wearable Technology for Arrhythmia Detection

Abstract Play Pause

Graphical Abstract

Related Journals

Related Books

Abstract